MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.28, ss.235-243, 2019 (SCI-Expanded)
Background: Exposure to disease-modifying therapy (DMT) during early pregnancy in women with relapsing-remitting MS (RAMS) may be increasing.